Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 5, group A, member 1 | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear receptor subfamily 5, group A, member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | nuclear receptor subfamily 5, group A, member 2 | 469 aa | 431 aa | 22.5 % |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | nuclear receptor subfamily 5, group A, member 1 | 461 aa | 460 aa | 32.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Lysosomal Pro X carboxypeptidase | 0.0412 | 0.0569 | 0.0569 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.1962 | 0.3616 | 0.4639 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.2709 | 0.5085 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.1962 | 0.3616 | 0.3616 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.3414 | 0.6471 | 0.6471 |
Plasmodium vivax | hypothetical protein, conserved | 0.0705 | 0.1145 | 0.5 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0705 | 0.1145 | 0.1145 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.1962 | 0.3616 | 0.3616 |
Loa Loa (eye worm) | hypothetical protein | 0.0705 | 0.1145 | 0.1145 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0705 | 0.1145 | 0.1145 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0705 | 0.1145 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0705 | 0.1145 | 0.1145 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0705 | 0.1145 | 0.5 |
Brugia malayi | hypothetical protein | 0.1257 | 0.2229 | 0.2229 |
Trypanosoma cruzi | oligopeptidase B-like protein, putative | 0.1591 | 0.2887 | 0.3271 |
Echinococcus granulosus | prolyl endopeptidase | 0.3414 | 0.6471 | 0.6471 |
Echinococcus granulosus | acylamino acid releasing enzyme | 0.0705 | 0.1145 | 0.1145 |
Trypanosoma brucei | oligopeptidase b | 0.1591 | 0.2887 | 0.3271 |
Trypanosoma brucei | serine peptidase, clan SC, family S9A-like protein | 0.1591 | 0.2887 | 0.3271 |
Brugia malayi | prolyl oligopeptidase family protein | 0.3414 | 0.6471 | 0.6471 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.3414 | 0.6471 | 1 |
Trypanosoma cruzi | oligopeptidase b | 0.1591 | 0.2887 | 0.3271 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.1962 | 0.3616 | 0.4639 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0705 | 0.1145 | 0.1145 |
Trypanosoma cruzi | oligopeptidase b | 0.1591 | 0.2887 | 0.3271 |
Trypanosoma brucei | prolyl oligopeptidase, putative | 0.1591 | 0.2887 | 0.3271 |
Plasmodium falciparum | peptidase, putative | 0.0705 | 0.1145 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.3414 | 0.6471 | 0.6471 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0705 | 0.1145 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0705 | 0.1145 | 0.5 |
Echinococcus granulosus | Lysosomal Pro X carboxypeptidase | 0.0412 | 0.0569 | 0.0569 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0705 | 0.1145 | 0.1145 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0705 | 0.1145 | 0.5 |
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0705 | 0.1145 | 0.1145 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.1962 | 0.3616 | 0.4639 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0705 | 0.1145 | 0.5 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0705 | 0.1145 | 0.5 |
Echinococcus granulosus | FTZ F1 alpha | 0.0489 | 0.0719 | 0.0719 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.1962 | 0.3616 | 0.3616 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0705 | 0.1145 | 0.5 |
Trypanosoma cruzi | serine peptidase, clan SC, family S9A-like protein, putative | 0.1591 | 0.2887 | 0.3271 |
Loa Loa (eye worm) | hypothetical protein | 0.1257 | 0.2229 | 0.2229 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.3414 | 0.6471 | 0.6471 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0705 | 0.1145 | 0.5 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.1591 | 0.2887 | 0.5 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.5209 | 1 | 1 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0705 | 0.1145 | 0.5 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.5209 | 1 | 1 |
Trypanosoma cruzi | prolyl endopeptidase | 0.3414 | 0.6471 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.1962 | 0.3616 | 0.3616 |
Toxoplasma gondii | prolyl endopeptidase | 0.3414 | 0.6471 | 1 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.1962 | 0.3616 | 0.2033 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.1591 | 0.2887 | 0.5 |
Schistosoma mansoni | family S28 unassigned peptidase (S28 family) | 0.0412 | 0.0569 | 0.0569 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0705 | 0.1145 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.1962 | 0.3616 | 0.4639 |
Echinococcus multilocularis | acylamino acid releasing enzyme | 0.0705 | 0.1145 | 0.1145 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.1683 | 0.1683 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.1962 | 0.3616 | 0.4639 |
Trypanosoma brucei | prolyl endopeptidase | 0.3414 | 0.6471 | 1 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.5209 | 1 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.3414 | 0.6471 | 0.6471 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.5209 | 1 | 1 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.5209 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 3.984 uM | PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2). (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 4.983 uM | PubChem BioAssay. Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1). (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 35.856 uM | PubChem BioAssay. Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.